Rallybio Corporation
RLYB
$16.99
$0.030.18%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 45.55M | -7.82M | -8.98M | -14.17M | -41.65M |
| Total Depreciation and Amortization | 43.00K | 67.00K | 92.00K | 119.00K | 116.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -19.74M | -18.43M | -16.74M | -15.34M | 8.40M |
| Change in Net Operating Assets | 858.00K | -1.41M | -4.19M | -5.61M | -8.86M |
| Cash from Operations | 26.71M | -27.59M | -29.81M | -35.00M | -41.99M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 56.55M | 54.09M | 47.27M | 41.77M | 34.75M |
| Cash from Investing | 56.55M | 54.09M | 47.27M | 41.77M | 34.75M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 140.00K | 19.00K | 16.00K | 28.00K | 28.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 0.00 | -11.00K |
| Cash from Financing | 140.00K | 19.00K | 16.00K | 28.00K | 17.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 83.40M | 26.52M | 17.47M | 6.80M | -7.23M |